V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160015900 | 160007891 | null | 70 | Palliative (P) | 2016-11-20 | 2016-11-21 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101625754 |
| 160015901 | 160007892 | 1.78 | 81.3 | 03 | 2016-12-23 | 2016-12-23 | CHOP R | null | N | NB HRNBL-1 COJEC IND COURSE A | 100329081 |
| 160015906 | 160007893 | 1.56 | 58.1 | Neo-adjuvant (N) | 2018-09-09 | 2018-09-23 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100119747 |
| 160015911 | 160007894 | 1.58 | 57.3 | Palliative (P) | 2019-02-03 | 2019-02-03 | GemCarbo Days 1+8 | N | N | CISPLATIN + PEMETREXED | 100997391 |
| 160015915 | 160007895 | 1.62 | 65.3 | Palliative (P) | 2017-11-15 | 2017-12-03 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100444599 |
| 160015916 | 160007896 | 1.76 | 63.9 | Palliative (P) | 2016-11-08 | 2016-11-08 | CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 101853045 |
| 160015919 | 160007897 | 1.68 | 61.2 | Palliative (P) | 2017-04-13 | 2017-04-13 | Doxorubicin + Ifosfamide | 02 | null | BEVACIZUMAB + CARBO + PACLITAXEL | 100351740 |
| 160015920 | 160007898 | 1.7 | 66.8 | Palliative (P) | 2016-08-18 | 2016-08-23 | Carboplatin + Paclitaxel (3 weekly) | N | null | DOCETAXEL | 101329591 |
| 160015923 | 160007899 | 1.65 | 84.35 | Palliative (P) | 2016-07-25 | 2016-08-05 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100331369 |
| 160015925 | 160007900 | 1.55 | 72.5 | Palliative (P) | 2017-01-13 | 2017-02-14 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100238209 |
| 160015930 | 160007901 | 1.66 | 63.4 | null | 2020-06-05 | 2020-06-05 | VIDE | 02 | N | LIPOSOMAL DOXORUBICIN | 101397810 |
| 160015932 | 160007902 | 1.73 | 69.6 | Palliative (P) | 2018-01-01 | 2018-01-02 | VIDE | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101462945 |
| 160015939 | 160007903 | 1.67 | 78.9 | Palliative (P) | 2016-05-13 | 2016-06-06 | TEMOZOLOMIDE | N | N | TRIAL | 100548305 |
| 160015941 | 160007904 | 1.75 | 93.9 | Neo-adjuvant (N) | 2017-07-19 | 2017-07-26 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100370126 |
| 160015943 | 160007905 | 1.7 | 56.2 | Palliative (P) | 2021-01-06 | 2021-02-07 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | EW EUROEWING 2012 ARM B VDC | 101679938 |
| 160015945 | 160007906 | 1.63 | 65.8 | Palliative (P) | 2016-09-02 | 2016-09-26 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100565318 |
| 160015946 | 160007907 | 1.69 | 47.8 | Disease modification (D) | 2019-05-14 | 2019-05-26 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100725581 |
| 160015947 | 160007908 | 1.65 | 58.8 | Palliative (P) | 2017-08-19 | 2017-08-20 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100407842 |
| 160015951 | 160007909 | 1.83 | 91 | Palliative (P) | 2018-10-27 | 2018-10-28 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100041219 |
| 160015952 | 160007910 | 1.9 | 88.6 | Palliative (P) | 2018-04-01 | 2018-04-22 | Vinorelbine (oral) | N | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100137761 |
| 160015955 | 160007912 | 1.65 | 72.9 | Palliative (P) | 2017-02-12 | 2017-02-27 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | LIPOSOMAL DOXORUBICIN | 101652703 |
| 160015956 | 160007913 | 1.73 | 75.6 | Palliative (P) | 2019-04-16 | 2019-04-17 | Doxorubicin + Ifosfamide | 01 | N | DA | 100776283 |
| 160015957 | 160007914 | 1.54 | 83.3 | Curative (C) | 2017-10-14 | 2017-10-20 | Trial Unspecified | N | N | GEMCARBO | 100876871 |
| 160015962 | 160007915 | null | null | null | 2016-09-11 | 2016-09-12 | Capecitabine | 02 | null | DOXORUBICIN + OLARATUMAB | 100350379 |
| 160015963 | 160007916 | 1.7 | 72.2 | Palliative (P) | 2019-08-10 | 2019-08-20 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100797334 |
| 160015965 | 160007917 | 1.77 | 54.4 | Palliative (P) | 2018-12-03 | 2018-12-12 | Doxorubicin + Olaratumab | 02 | null | CARBOPLATIN | 101565750 |
| 160015969 | 160007918 | 1.8 | 63.2 | Palliative (P) | 2016-06-18 | 2017-05-05 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101127652 |
| 160015971 | 160007919 | 1.72 | 79 | null | 2018-03-03 | 2018-04-01 | CARBOPLATIN + PACLITAXEL | null | N | CARBOPLATIN + PACLITAXEL | 101396540 |
| 160015972 | 160007920 | 1.78 | null | null | 2016-10-15 | 2016-10-19 | Trial Unspecified | N | null | GEMCARBO | 100960491 |
| 160015973 | 160007921 | 1.7 | 12.9 | null | 2019-06-07 | 2019-06-08 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | 02 | N | TRABECTEDIN | 100533153 |
| 160015974 | 160007922 | 1.6 | 84.7 | Palliative (P) | null | 2018-01-17 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101608275 |
| 160015976 | 160007923 | 1.72 | 93.6 | Curative (C) | 2018-01-05 | 2018-01-05 | Cisplatin + Pemetrexed | 01 | N | PEMETREXED | 101305792 |
| 160015978 | 160007924 | 1.73 | 59.8 | Palliative (P) | 2018-06-18 | 2018-07-06 | Cyclophosphamide + Docetaxel | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101061501 |
| 160015979 | 160007925 | 1.78 | 80 | Neo-adjuvant (N) | 2017-10-09 | 2017-10-09 | EW EuroEwing 2012 Arm B VDC | null | N | IMATINIB | 101428360 |
| 160015985 | 160007926 | 1.63 | 70.8 | Palliative (P) | 2018-06-14 | 2018-06-14 | EW EuroEwing 2012 Arm B VDC | 01 | N | PACLITAXEL | 101625524 |
| 160015988 | 160007928 | null | null | null | 2021-03-15 | 2021-03-20 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101831133 |
| 160015993 | 160007929 | 1.65 | 59.8 | Adjuvant (A) | 2016-08-07 | 2016-08-23 | Carboplatin + Paclitaxel (3 weekly) | N | null | CARBOPLATIN + PACLITAXEL | 100967298 |
| 160015995 | 160007930 | 1.65 | 60.7 | Neo-adjuvant (N) | 2019-07-04 | 2019-07-15 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | null | DOXORUBICIN + IFOSFAMIDE | 100952151 |
| 160015996 | 160007931 | 1.7 | 75 | Palliative (P) | 2019-08-02 | 2019-08-13 | CARBOPLATIN + PACLITAXEL | N | null | CARBOPLATIN + PACLITAXEL | 100967871 |
| 160015998 | 160007932 | 1.78 | 98.6 | Palliative (P) | 2016-11-13 | 2016-11-15 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100933905 |
| 160016000 | 160007933 | 1.63 | 78 | Palliative (P) | 2016-09-23 | 2016-09-27 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101644512 |
| 160016004 | 160007934 | 1.8 | 93.3 | Curative (C) | 2016-04-25 | 2016-05-03 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100927957 |
| 160016007 | 160007935 | 1.63 | 109 | Palliative (P) | 2016-02-24 | 2016-03-09 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100885300 |
| 160016008 | 160007936 | 1.86 | 73.45 | 03 | null | 2017-10-31 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101016904 |
| 160016009 | 160007937 | 1.7 | 69.2 | Palliative (P) | 2019-08-18 | 2019-08-23 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100356006 |
| 160016010 | 160007938 | 1.5 | 70 | Palliative (P) | 2021-04-29 | 2021-05-01 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100349193 |
| 160016012 | 160007939 | 1.57 | 59.4 | Neo-adjuvant (N) | 2017-02-23 | 2017-03-02 | CARBOPLATIN + GEMCITABINE | 02 | N | DOXORUBICIN | 101577391 |
| 160016013 | 160007940 | 1.76 | 90.1 | Palliative (P) | 2019-04-27 | 2019-05-08 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101056904 |
| 160016016 | 160007942 | 1.66 | 62.45 | null | 2016-02-25 | 2016-04-03 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101728123 |
| 160016018 | 160007943 | 1.66 | 52.6 | null | 2019-10-06 | 2019-10-25 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100218015 |